z-logo
open-access-imgOpen Access
Targeting GGTase-I Activates RHOA, Increases Macrophage Reverse Cholesterol Transport, and Reduces Atherosclerosis in Mice
Author(s) -
Omar M. Khan,
Murali K. Akula,
Kristina Skålén,
Christin Karlsson,
Marcus Ståhlman,
Stephen G. Young,
Jan Borén,
Martin O. Bergö
Publication year - 2013
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.112.000588
Subject(s) - rhoa , scavenger receptor , cd36 , geranylgeranylation , inflammation , macrophage , proinflammatory cytokine , endocrinology , cholesterol , medicine , foam cell , chemistry , receptor , microbiology and biotechnology , biology , lipoprotein , signal transduction , prenylation , biochemistry , in vitro , enzyme
Statins have antiinflammatory and antiatherogenic effects that have been attributed to inhibition of RHO protein geranylgeranylation in inflammatory cells. The activity of protein geranylgeranyltransferase type I (GGTase-I) is widely believed to promote membrane association and activation of RHO family proteins. However, we recently showed that knockout of GGTase-I in macrophages activates RHO proteins and proinflammatory signaling pathways, leading to increased cytokine production and rheumatoid arthritis. In this study, we asked whether the increased inflammatory signaling of GGTase-I-deficient macrophages would influence the development of atherosclerosis in low-density lipoprotein receptor-deficient mice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom